Growth Metrics

QuidelOrtho (QDEL) EBIT (2021 - 2024)

QuidelOrtho's EBIT history spans 3 years, with the latest figure at -$618.1 million for Q4 2023.

  • For Q4 2023, EBIT fell 296.6% year-over-year to -$618.1 million; the TTM value through Dec 2023 reached -$560.9 million, down 138.54%, while the annual FY2024 figure was -$2.0 billion, 1509.71% down from the prior year.
  • EBIT for Q4 2023 was -$618.1 million at QuidelOrtho, down from -$15.5 million in the prior quarter.
  • Across five years, EBIT topped out at $620.7 million in Q2 2022 and bottomed at -$618.1 million in Q4 2023.
  • The 3-year median for EBIT is $78.2 million (2022), against an average of $134.1 million.
  • The largest annual shift saw EBIT soared 1889.7% in 2022 before it plummeted 296.6% in 2023.
  • A 3-year view of EBIT shows it stood at $423.1 million in 2021, then crashed by 86.58% to $56.8 million in 2022, then plummeted by 1188.2% to -$618.1 million in 2023.
  • Per Business Quant, the three most recent readings for QDEL's EBIT are -$618.1 million (Q4 2023), -$15.5 million (Q4 2023), and -$26.9 million (Q3 2023).